STAT+: New treatments for common cardiovascular risk factor near the market, with billions at stake
High cholesterol can be managed with medicine, but high Lp(a) levels, another common cardiovascular risk, cannot. Drugmakers are hoping to change that.
خواندن متن کامل در استتنیوزبه زبان اصلی، در سایت ناشر باز میشودمتن اصلی (انگلیسی)
STAT+: New treatments for common cardiovascular risk factor near the market, with billions at stake
High cholesterol can be managed with medicine, but high Lp(a) levels, another common cardiovascular risk, cannot. Drugmakers are hoping to change that.